Sign In
Buy MEDIF
$0.0539
-0.0024 (-4.33%)
At Close: Jun 03, 2026
MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority
06:30am, Wednesday, 07'th Feb 2024
MediPharm Labs is the first purpose-built pharmaceutical cannabis company in North America to receive a GMP certificate from the Brazilian Health Regulatory Agency (ANVISA), for production of cannabis
MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program
07:00am, Friday, 22'nd Dec 2023
TORONTO , Dec. 22, 2023 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-bas
MediPharm Labs Corp. (MEDIF) Q3 2023 Earnings Call Transcript
11:24am, Tuesday, 14'th Nov 2023
MediPharm Labs Corp. (OTCQB:MEDIF) Q3 2023 Earnings Conference Call November 14, 2023 8:30 AM ET Company Participants David Pidduck - Chief Executive Officer Keith Strachan - President Greg Hunter - C
MediPharm Labs Reports Third Quarter Results
07:15am, Tuesday, 14'th Nov 2023
Achieves Higher Gross Margin, Moves Closer to Profitability TORONTO , Nov. 14, 2023 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "C
MediPharm Labs Sets Date to Report Third Quarter 2023 Financial Results
05:01pm, Wednesday, 08'th Nov 2023
TORONTO , Nov. 8, 2023 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-base
MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to Cash
07:00am, Wednesday, 25'th Oct 2023
TORONTO , Oct. 25, 2023 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a company specialized in precision-based cannabinoids
MediPharm Labs Settles an Outstanding Claim for $9M
07:00am, Monday, 02'nd Oct 2023
TORONTO , Oct. 2, 2023 /PRNewswire/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a company specialized in precision-based cannabinoids,
MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market
07:15am, Wednesday, 27'th Sep 2023
The launch includes GMP strain-specific full spectrum cannabis oil and inhalation cartridge products to be distributed to patients under the MediPharm Labs Beacon Medical brand. As of July 2023, al
MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty Agreement
07:00am, Wednesday, 20'th Sep 2023
MediPharm Labs and Shelter Cannabis Brands have terminated their royalty agreement with a one-time cash payment. Agreement includes the elimination of ongoing royalty payments, for a one-time lump sum
MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million
07:39am, Tuesday, 05'th Sep 2023
MediPharm Labs sold vacant land in Napanee, Ontario last utilized in 2021 for outdoor cannabis growing activities. The land was acquired by MediPharm as part of the VIVO Cannabis acquisition in April
Top Marijuana Penny Stocks for September 2023
07:30am, Friday, 01'st Sep 2023
Welcome to the worldwide arena of marijuana stocks in the ever-changing cannabis sector, where the intersection of financial prospects and rising legality is creating a buzz unlike any other. As we ap
Medical cannabis may help manage fibromyalgia, study finds
08:30am, Thursday, 31'st Aug 2023
Medical cannabis may play a role in managing fibromyalgia and related symptoms of depression and anxiety, according to a peer-reviewed study published in the American Journal of Endocannabinoid Medici
MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia Patients
08:02am, Thursday, 31'st Aug 2023
MediPharm Labs wholly owned subsidiary Harvest Medicine has published a study in the peer-reviewed American Journal of Endocannabinoid Medicine. This is the largest peer reviewed published study of it
Avicanna and Medipharm Labs extend manufacturing deal for SEDDS cannabinoid technology capsules
08:42am, Monday, 26'th Jun 2023
Avicanna Inc (TSX:AVCN, OTCQX:AVCNF) has announced the extension of its existing strategic manufacturing agreement with MediPharm Labs (TSX-V:LABS) Inc for the commercialization of Avicanna's propriet
MediPharm Labs Corp. (MEDIF) Q4 2022 Earnings Call Transcript
02:19pm, Monday, 15'th May 2023
MediPharm Labs Corp. (OTCQX:MEDIF) Q4 2022 Earnings Conference Call May 15, 2023 8:30 AM ET Company Participants David Pidduck - CEO Keith Strachan - President Greg Hunter - CFO Conference Call Partic
